Oncology
5,176 studies502 in 7 days2,477 in 30 days
Filters
Latest
5,176 studies
- Advancing Glioblastoma Supportive Care: Closing the Caregiver Gap
- Diagnostic Value in Discarded Reads: Re-evaluating Multi-Mapping cfDNA Fragmentomics and GC Bias in Early-Stage Cancer.
- 224 Preclinical evaluation of a claudin18.2-sensing, membrane-proximal mesothelin-targeted SNIPR CAR-T platform for pancreatic cancer and other solid tumors
- 715 Proteotoxic stress programs pathologic lipid storage and metabolic dysfunction in intratumoral CD8+ T cells
- 473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer
- 445 Co-mutation architecture shapes immunotherapy outcomes in KRAS-mutant NSCLC: real-world evidence from AACR GENIE BPC cohort
- The Colonic Mucosectomy Flap for Perineal Reconstruction after Major Pelvic Excision: A Single-Center Experience
- Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum
- Association Between Hospital Size and Outcomes of ES-SCLC Treated with Chemo-ICI: A Real-World Database Study in Japan
- Radiotherapy-Conditioned Antibody–Drug Conjugate Activity: Molecular Mechanisms, Therapeutic Windows and Organ-Specific Toxicity
- Beyond White-Light Colonoscopy: Water Exchange, Image-Enhanced Endoscopy, and Artificial Intelligence for Colorectal Neoplasia Detection—From Single Tools to Combined Strategies: A Scoping Review
- Intracranial Activity of Deruxtecan-Based Antibody–Drug Conjugates in Non-Small Cell Lung Cancer Brain Metastases: A Systematic Review and Meta-Analysis of Prospective Trial Cohorts
- The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer
- Real-World Effectiveness and Safety of Tarlatamab in Small Cell Lung Cancer: A Systematic Review
- From ancient remedy to modern use: cannabis and cannabinoids in cancer care in the United States
- Artificial intelligence and triple negative breast cancer: can pathomics help oncologists?
- CAR-T and CAR-NK cell therapy targets in gastrointestinal malignancies: a narrative review of clinical evidence and future directions
- Prediction models for progression to castration-resistant prostate cancer after androgen deprivation therapy: a narrative review (2021–2026)
- Factors associated with cancer-related fatigue in breast cancer patients: a systematic review and meta-analysis
- Umbrella review of meta-analyses: perioperative immune checkpoint inhibitor therapy in resectable gastric and gastroesophageal junction adenocarcinoma
- Haematopoietic stem cell transplantation for juvenile myelomonocytic leukaemia: a descriptive single-centre case series from a resource-limited setting
- Case Report: Long-term survival of a patient with lung adenocarcinoma harboring EGFR 19del/T790M/C797S and KIF26B-NTRK1 rearrangement
- Incidence and risk factors of chemotherapy-induced diarrhea in colorectal cancer patients based on a random forest model
- Commentary: Assessment of real-world surveillance strategies for patients undergoing systemic therapy for brain metastases
- Cardiovascular risk after breast cancer chemotherapy in a hospital-based real-word study from Northwest China